Skip to main navigation

Fate Therapeutics

0
Skip to content
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
  • Pipeline
    • Overview
    • Immuno-Oncology Candidates
      • Fate-NK100
      • FT500
      • Engineered hnCD16iNK
      • Engineered CAR iT Cell
    • Immuno-Regulation Candidates
      • ProTmune™
      • ToleraCyte™
  • Science
    • Ex Vivo Cell Modulation
    • iPSC Product Platform
    • ISSCR Annual Meeting and Presentations
      • ISSCR 2017 Annual Meeting
      • ISSCR 2016 Annual Meeting
    • Publications
  • Collaborations
  • Join Our Team
    • Career Opportunities
    • Vision, Mission, Values
    • Working at Fate
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
    • Investors FAQs

Financials & Filings

ANNUAL REPORTS

Title View
2018 Annual Report 9.6 MB
2018 Annual Report 9.6 MB
2017 Annual Report 4 MB
2017 Annual Report 4 MB

PROXY STATEMENTS

Filing date View
Apr 02, 2015 View HTML
0001104659-15-025524.pdf
0001104659-15-025524.xls
Mar 30, 2016 View HTML
0001193125-16-522270.pdf
0001193125-16-522270.xls

FORM 10-K

Filing date View
Mar 17, 2014 View HTML
0001047469-14-002516.pdf
0001047469-14-002516.xls
Mar 12, 2015 View HTML
0001047469-15-002070.pdf
0001047469-15-002070.xls

FORM 10-Q

Filing date View
Nov 13, 2013 View HTML
0001104659-13-084191.pdf
0001104659-13-084191.xls
May 13, 2014 View HTML
0001104659-14-038138.pdf
0001104659-14-038138.xls

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

© 2019 Fate Therapeutics | 3535 General Atomics Court, Suite 200, San Diego 92121 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
  • Pipeline
    • Overview
    • Immuno-Oncology Candidates
      • Fate-NK100
      • FT500
      • Engineered hnCD16iNK
      • Engineered CAR iT Cell
    • Immuno-Regulation Candidates
      • ProTmune™
      • ToleraCyte™
  • Science
    • Ex Vivo Cell Modulation
    • iPSC Product Platform
    • ISSCR Annual Meeting and Presentations
      • ISSCR 2017 Annual Meeting
      • ISSCR 2016 Annual Meeting
    • Publications
  • Collaborations
  • Join Our Team
    • Career Opportunities
    • Vision, Mission, Values
    • Working at Fate
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact